GAMBARO, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 14.062
NA - Nord America 12.851
AS - Asia 10.830
SA - Sud America 2.361
AF - Africa 244
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 8
Totale 40.392
Nazione #
US - Stati Uniti d'America 12.658
RU - Federazione Russa 6.404
SG - Singapore 4.789
CN - Cina 3.090
GB - Regno Unito 2.083
BR - Brasile 1.904
FR - Francia 1.102
HK - Hong Kong 1.083
IE - Irlanda 1.083
VN - Vietnam 862
IT - Italia 846
SE - Svezia 716
DE - Germania 657
FI - Finlandia 478
UA - Ucraina 352
KR - Corea 280
AR - Argentina 198
ID - Indonesia 111
IN - India 101
EC - Ecuador 87
CA - Canada 85
JP - Giappone 77
BD - Bangladesh 76
MX - Messico 59
ZA - Sudafrica 59
TR - Turchia 52
NL - Olanda 50
PK - Pakistan 48
IQ - Iraq 44
AT - Austria 41
PL - Polonia 41
BE - Belgio 40
ES - Italia 37
VE - Venezuela 37
BJ - Benin 35
TG - Togo 33
CO - Colombia 32
PY - Paraguay 32
MA - Marocco 28
AU - Australia 27
CL - Cile 27
IL - Israele 26
UZ - Uzbekistan 24
UY - Uruguay 20
EG - Egitto 17
GR - Grecia 16
KZ - Kazakistan 16
TN - Tunisia 16
AZ - Azerbaigian 14
KE - Kenya 14
PE - Perù 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
DZ - Algeria 13
JO - Giordania 11
RO - Romania 11
CZ - Repubblica Ceca 10
IR - Iran 10
KG - Kirghizistan 9
PH - Filippine 9
SK - Slovacchia (Repubblica Slovacca) 9
AL - Albania 8
BO - Bolivia 8
LB - Libano 8
TH - Thailandia 8
BG - Bulgaria 7
HN - Honduras 7
HR - Croazia 7
LT - Lituania 7
NO - Norvegia 7
NP - Nepal 7
BH - Bahrain 6
CR - Costa Rica 6
DK - Danimarca 6
GT - Guatemala 6
SA - Arabia Saudita 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
KW - Kuwait 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
AM - Armenia 4
AO - Angola 4
EE - Estonia 4
EU - Europa 4
GE - Georgia 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
PS - Palestinian Territory 4
SN - Senegal 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
HU - Ungheria 3
NI - Nicaragua 3
PR - Porto Rico 3
Totale 40.335
Città #
Jacksonville 2.017
Singapore 2.010
Moscow 1.779
Southend 1.757
Chandler 1.325
Dallas 1.283
Ashburn 1.088
Dublin 1.080
Hong Kong 1.076
Woodbridge 754
Beijing 537
Houston 485
Princeton 418
Lawrence 417
Ann Arbor 405
Wilmington 371
The Dalles 343
Ho Chi Minh City 324
Jinan 221
Los Angeles 208
New York 208
Buffalo 181
Redondo Beach 181
Nanjing 177
Hanoi 164
São Paulo 163
Verona 160
Shenyang 152
Columbus 144
Sindelfingen 136
Tianjin 123
Hebei 113
Helsinki 94
Redmond 93
Seattle 91
Milan 87
Changsha 74
London 73
Nanchang 73
Tokyo 72
Zhengzhou 70
Guangzhou 68
Santa Clara 67
Munich 65
Ningbo 62
Boardman 60
Haikou 60
Rio de Janeiro 60
Norwalk 58
Taizhou 53
Taiyuan 47
Nuremberg 44
Jiaxing 43
Redwood City 42
Brussels 40
Fairfield 38
Hangzhou 38
San Francisco 38
Council Bluffs 37
Jakarta 37
Chicago 36
Turku 36
Belo Horizonte 35
Cotonou 35
Brasília 34
Brooklyn 34
Warsaw 34
Lomé 33
Montreal 31
Frankfurt am Main 30
Quito 30
Haiphong 29
Lanzhou 28
Da Nang 25
Denver 25
Dong Ket 25
Dongguan 25
Lancaster 25
Lappeenranta 25
Porto Alegre 25
Bologna 24
Fuzhou 24
Phoenix 24
Seoul 24
Campinas 23
Chennai 23
Falls Church 23
Toronto 23
Amsterdam 22
Biên Hòa 22
Stockholm 22
Atlanta 21
Buenos Aires 21
Johannesburg 21
Shanghai 21
Tashkent 21
Vienna 21
Curitiba 20
Guayaquil 20
Hải Dương 20
Totale 22.524
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 454
Placche di Randall e calcolosi ossalo-calcica idiopatica: quale ruolo e quale futuro? 237
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 231
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 221
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. 213
Age dependence of within-subject biological variation of nine common clinical chemistry analytes 182
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 178
[Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis]. 171
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 163
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 162
mTOR inhibitors and renal allograft: Yin and Yang. 161
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 161
A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. 161
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 157
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 156
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 156
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 153
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 153
Placche di Randal e calcolosi ossalocalcica idiopatica: quale ruolo e quale futuro? 152
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 152
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 152
A genome-wide association study of anorexia nervosa 152
[Physical, chemical and morphological urine examination guidelines for the Analytical Phase from the Intersociety Urinalysis Group] 151
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 150
[Dent's disease: hereditary nephrolithiasis related to defective tubular endocytosis processes] 147
[In search of renal stem cells] 146
Unusual renal presentation of Fabry disease in a female patient. 145
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 145
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 143
Sulodexide and glycosaminoglycans in the progression of renal disease. 143
[Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis]. 143
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 142
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 142
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 142
A validated model of disease progression in IgA nephropathy. 141
Does Randall’s plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? 140
A Delphi consensus panel on nutritional therapy in chronic kidney disease 140
Detection of a large deletion in the P-selectin (SELP) gene 139
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 139
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 138
Donor-transmitted cancer in kidney transplant recipients: a systematic review 137
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 136
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 136
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 135
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 135
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 134
A comparative kinetic RT/-PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens. 132
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 132
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 131
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 130
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 130
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 129
Henoch-Schonlein purpura and Crohn's disease in a family. 128
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 128
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 128
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 128
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 128
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 128
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 127
Invecchiamento e funzionalità renale: indagine prospettica in una coorte di soggetti anziani in buone condizioni di salute 126
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 125
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 125
[Hyponatremia: practical approach to diagnosis and treatment] 125
LIVER-KIDNEY-TRANSPLANTATION IN TYPE 1 PRIMARY HYPEROXALURIA: DESCRIPTION AND COMMENTS ON A CASE. 124
General practitioners' serum creatinine recording styles. 124
Heparanase as a target in cancer therapy. 124
Directional dominance on stature and cognition in diverse human populations. 124
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 124
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 123
Modulation of miR-204 expression during chondrogenesis 123
[Gout and kidney during XVII and XIX centuries] 122
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 122
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 122
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 122
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 122
The Role of prEoperative ultraSonography on patenCy of native arteriovenoUs accEss: RESCUE Study (in press) 121
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 121
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 120
A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update 120
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease 119
Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients 118
Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. 117
ADVANCES IN REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ANALYSIS OF CELLULAR mRNA LEVELS OF TRANSFORMING GROWTH FACTOR-BETA1 BY CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION. 117
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. 117
QUANTITATION OF TGF-BETA1 mRNA IN PORCINE MESANGIAL CELLS BY COMPARATIVE KINETIC RT/PCR: COMPARISON WITH RIBONUCLEASE PROTECTION ASSAY AND IN SITU HYBRIDIZATION. 116
SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function 116
The Genetics of Kidney Stones 116
Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation 115
Heparanase: another renal player controlled by vitamin d. 115
Hyperchloremia and acute kidney injury: a retrospective observational cohort study on a general mixed medical-surgical not ICU-hospitalized population 115
Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis 114
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 113
[PHYSICAL, CHEMICAL AND MORPHOLOGICAL URINE EXAMINATION: RECOMMENDATIONS FOR THE POST ANALYTICAL PHASE FROM THE INTERDISCIPLINARY URINALYSIS GROUP (GIAU)] 113
Diagnosis of acute renal injury by serum creatinine: negative perception vs evidence 112
[Uric acid nephrolithiasis] 112
Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy 112
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. 111
Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment 111
Renin-angiotensin system (RAS) DNA polymorphisms and TGFbeta1-mediated fibrogenetic pathway gene expression studies in primary IgA naphropathy (Berger’s disease). 110
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients. 110
Totale 14.004
Categoria #
all - tutte 158.300
article - articoli 148.729
book - libri 0
conference - conferenze 4.714
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.857
Totale 316.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.320 0 0 0 0 0 376 35 203 161 32 372 141
2021/20222.210 109 498 12 194 75 27 38 187 107 113 138 712
2022/20234.960 494 381 676 609 536 1.278 27 277 445 30 138 69
2023/20242.874 105 226 247 232 277 404 73 559 27 90 386 248
2024/20257.903 481 577 277 1.295 324 190 354 442 1.181 514 594 1.674
2025/202614.068 1.620 1.391 1.919 3.865 4.977 296 0 0 0 0 0 0
Totale 41.006